✦ LIBER ✦

163 Amifostine in low-risk and combined therapy with gemcitabine in high-risk myelodysplastic syndromes

✍ Scribed by O. Sezer; M. Stefanic; G. Dingeldein; H.-G. Mergenthaler; K. Possinger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

419 - Combined therapy of amifostine and

✍ O. Sezer; G. Oingeldein; H.-G. Mergenthaler; K. Possinger 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Amifostine plus erythropoietin in a pati

✍ E. Musch; M. Malek; A. Chrissafidou 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 138 KB

Survivin expression in “low-risk” and “h

✍ Umberto Gianelli; Nicola Stefano Fracchiolla; Agostino Cortelezzi; Caterina Pell 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 166 KB

Response Assessments in Low-Risk and Hig

✍ Pierre Fenaux 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Treatment of anemia in low-risk myelodys

✍ N. Viniou; E. Terpos; A. Galanopoulos; E. Kritikou-Griva; S. Akel; E. Michalis; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 36 KB

Iron overload and chelation therapy in p

✍ Angel F. Remacha; Beatriz Arrizabalaga; Consuelo Del Cañizo; Guillermo Sanz; Ana 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 147 KB